A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
INCYTE CORPORATION
Cita
A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis. (INCB 18424-319). INCYTE CORPORATION. 2023IP:ANTONIO MARTORELL CALATAYUD.
Portal de investigación